# Phase 3 asthma trials recruiting: 38 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 38 trials in phase 3 for asthma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 asthma trials: 38 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/asthma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 38
- Recruiting or not yet: 38
- Read on: November 19, 2026

## Trials

The 25 newest of 38, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 13, 2026 | NCT07934420 | An Efficacy and Safety Study to Assess an Inhaled, Fixed-dose, Budesonide/Formoterol Fumarate in Participants Aged 4 to Less Than 12 Years... | AstraZeneca | Phase 3 | Not yet recruiting | Asthma | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934420) |
| October 9, 2026 | NCT07869043 | A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma | Pfizer | Phase 3 | Recruiting | Asthma | 1,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869043) |
| October 5, 2026 | NCT07858123 | Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma | Chiesi Farmaceutici S.p.A. | Phase 3 | Not yet recruiting | Asthma | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858123) |
| August 24, 2026 | NCT07782996 | A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST... | GlaxoSmithKline | Phase 3 | Recruiting | Asthma | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782996) |
| August 21, 2026 | NCT07780643 | A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST... | GlaxoSmithKline | Phase 3 | Recruiting | Asthma | 514 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780643) |
| August 19, 2026 | NCT07772921 | A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma | Pfizer | Phase 3 | Recruiting | Asthma | 1,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07772921) |
| August 17, 2026 | NCT07768891 | Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma | Lunan Better Pharmaceutical Co., LTD. | Phase 3 | Recruiting | Asthma (Diagnosis) | 416 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768891) |
| June 26, 2026 | NCT07671001 | A Study of Depemokimab in Participants of 6 to 11 Years of Age | GlaxoSmithKline | Phase 3 | Recruiting | Asthma | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07671001) |
| June 12, 2026 | NCT07645248 | A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and... | GlaxoSmithKline | Phase 3 | Recruiting | Asthma | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645248) |
| April 23, 2026 | NCT07546981 | Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids... | Chiesi Farmaceutici S.p.A. | Phase 3 | Recruiting | Asthma | 554 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07546981) |
| March 6, 2026 | NCT07456033 | A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma | GlaxoSmithKline | Phase 3 | Recruiting | Asthma | 456 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07456033) |
| March 3, 2026 | NCT07444567 | Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued... | AstraZeneca | Phase 3 | Recruiting | Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES) | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07444567) |
| January 23, 2026 | NCT07363642 | Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab | AstraZeneca | Phase 3 | Recruiting | Severe Asthma | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07363642) |
| January 22, 2026 | NCT07359846 | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) | Generate Biomedicines | Phase 3 | Recruiting | Severe Asthma | 786 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359846) |
| December 30, 2025 | NCT07309614 | A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma | Université de Sherbrooke | Phase 3 | Recruiting | Asthma Control | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07309614) |
| December 24, 2025 | NCT07302516 | Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma | Qilu Pharmaceutical Co., Ltd. | Phase 3 | Not yet recruiting | Asthma | 636 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07302516) |
| December 11, 2025 | NCT07276724 | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1) | Generate Biomedicines | Phase 3 | Recruiting | Severe Asthma | 786 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07276724) |
| August 1, 2025 | NCT07098403 | A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma | Guangdong Hengrui Pharmaceutical Co., Ltd | Phase 3 | Recruiting | Asthma | 408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07098403) |
| June 10, 2025 | NCT07013123 | Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated... | University Hospital, Montpellier | Phase 3 | Not yet recruiting | Severe Asthma, Allergy to House Dust Mites | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07013123) |
| May 18, 2025 | NCT06979323 | Depemokimab Asthma Imaging and Bronchoscopy Sub-Study | GlaxoSmithKline | Phase 3 | Recruiting | Asthma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06979323) |
| March 26, 2025 | NCT06895460 | A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria... | The First Affiliated Hospital with Nanjing Medical University | Phase 3 | Not yet recruiting | Bronchial Asthma | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06895460) |
| February 20, 2025 | NCT06837922 | Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma | Shanghai Mabgeek Biotech.Co.Ltd | Phase 3 | Recruiting | Asthma | 504 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06837922) |
| February 17, 2025 | NCT06829784 | TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Phase 3 | Recruiting | Asthma | 660 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06829784) |
| January 21, 2025 | NCT06785272 | Magnesium Trial in Acute Asthma in Emergency Department | Sponsor not shown (see the record) | Phase 3 | Recruiting | Asthma | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06785272) |
| December 18, 2024 | NCT06740045 | Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe Asthma | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Asthma, Chronic Rhinosinusitis With Nasal Polyps | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06740045) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 6 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 6 |
| [Inmunotek S.L.](https://specstream.ai/data/clinical-trials/company/inmunotek-s-l) | 3 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 2 |
| Generate Biomedicines | 2 |
| [Chiesi Farmaceutici S.p.A.](https://specstream.ai/data/clinical-trials/company/chiesi-farmaceutici-s-p-a) | 2 |
| Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 1 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 1 |
| University Hospital, Montpellier | 1 |
| Lunan Better Pharmaceutical Co., LTD. | 1 |
| [Guangdong Hengrui Pharmaceutical Co., Ltd](https://specstream.ai/data/clinical-trials/company/guangdong-hengrui-pharmaceutical-co-ltd) | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| University of KwaZulu | 1 |
| Shanghai Mabgeek Biotech.Co.Ltd | 1 |
| [Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.](https://specstream.ai/data/clinical-trials/company/sunshine-guojian-pharmaceutical-shanghai-co-ltd) | 1 |
| Université de Sherbrooke | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 13 |
| China | 12 |
| Spain | 9 |
| United Kingdom | 7 |
| Argentina | 6 |
| Canada | 6 |
| Italy | 6 |
| South Africa | 6 |
| France | 5 |
| Hungary | 4 |
| Japan | 4 |
| Netherlands | 4 |
| Romania | 4 |
| South Korea | 4 |
| Germany | 4 |
| Brazil | 3 |
| Colombia | 3 |
| Mexico | 3 |
| Poland | 3 |
| Turkey (Türkiye) | 3 |
| Greece | 3 |
| Belgium | 3 |
| India | 3 |
| Philippines | 2 |
| Ukraine | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Traffic ticketing law firms in the United States](https://specstream.ai/data/businesses/traffic-ticketing-law-firms/united-states)
- [Office cleaning companies in the United States](https://specstream.ai/data/businesses/office-cleaning-companies/united-states)
- [Fish and chips restaurants in the United States](https://specstream.ai/data/businesses/fish-and-chips-restaurants/united-states)
- [Bars in the United States](https://specstream.ai/data/businesses/bars/united-states)
- [Speech therapy clinics in the United States](https://specstream.ai/data/businesses/speech-therapy-clinics/united-states)
- [Maternity centers in the United States](https://specstream.ai/data/businesses/maternity-centers/united-states)
